Zurcher Kantonalbank (Zurich Cantonalbank) Biotechnology

Zurcher Kantonalbank (Zurich Cantonalbank)

$34.1 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
BEAM Beam Therapeutics Inc.	$1.37B	$561,000 0.0% of portfolio	22,629	Q4 2024 Added 5.76%
GERN Geron Corp	$537M	$532,000 0.0% of portfolio	150,308	Q4 2024 Added 43.25%
IDYA Ideaya Biosciences, Inc.	$913M	$516,000 0.0% of portfolio	20,087	Q4 2024 Reduced 3.28%
RYTM Rhythm Pharmaceuticals, Inc.	$3.55B	$505,000 0.0% of portfolio	9,034	Q4 2024 Reduced 0.74%
RCUS Arcus Biosciences, Inc.	$599M	$494,000 0.0% of portfolio	33,224	Q4 2024 Added 7.94%
KYMR Kymera Therapeutics, Inc.	$1.82B	$480,000 0.0% of portfolio	11,954	Q4 2024 Added 5.89%
XNCR Xencor Inc	$627M	$451,000 0.0% of portfolio	19,631	Q4 2024 Added 38.1%
RXRX Recursion Pharmaceuticals, Inc.	$1.03B	$449,000 0.0% of portfolio	66,458	Q4 2024 Added 26.51%
WVE Wave Life Sciences Ltd.	$575M	$444,000 0.0% of portfolio	35,959	Q4 2024 Added 7.37%
BCRX Biocryst Pharmaceuticals Inc	$1.56B	$438,000 0.0% of portfolio	58,246	Q4 2024 Added 14.18%
MIRM Mirum Pharmaceuticals, Inc.	$1.5B	$438,000 0.0% of portfolio	10,600	Q4 2024 Added 9.18%
ACAD Acadia Pharmaceuticals Inc	$2.38B	$437,000 0.0% of portfolio	23,867	Q4 2024 Reduced 0.4%
IOVA Iovance Biotherapeutics, Inc.	$554M	$434,000 0.0% of portfolio	58,771	Q4 2024 Reduced 0.68%
SWTX Spring Works Therapeutics, Inc.	$2.79B	$422,000 0.0% of portfolio	11,685	Q4 2024 Added 28.07%
AGIO Agios Pharmaceuticals, Inc.	$1.61B	$421,000 0.0% of portfolio	12,836	Q4 2024 Added 5.8%
CLDX Celldex Therapeutics, Inc.	$915M	$402,000 0.0% of portfolio	15,930	Q4 2024 Added 12.89%
ARQT Arcutis Biotherapeutics, Inc.	$879M	$400,000 0.0% of portfolio	28,780	Q4 2024 Added 53.4%
ARDX Ardelyx, Inc.	$806M	$386,000 0.0% of portfolio	74,853	Q4 2024 Added 18.59%
NTLA Intellia Therapeutics, Inc.	$632M	$376,000 0.0% of portfolio	32,255	Q4 2024 Added 19.88%
PTGX Protagonist Therapeutics, Inc	$2.18B	$374,000 0.0% of portfolio	9,702	Q4 2024 Reduced 1.28%
DYN Dyne Therapeutics, Inc.	$573M	$371,000 0.0% of portfolio	15,751	Q4 2024 Added 68.77%
VRDN Viridian Therapeutics, Inc.\De	$529M	$357,000 0.0% of portfolio	18,664	Q4 2024 Added 33.34%
INVA Innoviva, Inc.	$1.27B	$348,000 0.0% of portfolio	20,063	Q4 2024 Added 9.63%
TVTX Travere Therapeutics, Inc.	$1.18B	$347,000 0.0% of portfolio	19,969	Q3 2024 Added 20.94%
VERA Vera Therapeutics, Inc.	$628M	$336,000 0.0% of portfolio	7,961	Q4 2024 Added 5.77%
MDXG Mimedx Group, Inc.	$785M	$323,000 0.0% of portfolio	33,623	Q1 2024 Added 11.83%
TARS Tarsus Pharmaceuticals, Inc.	$1.33B	$322,000 0.0% of portfolio	5,821	Q4 2024 Reduced 4.18%
ADPT Adaptive Biotechnologies Corp	$1.13B	$313,000 0.0% of portfolio	52,275	Q4 2024 New
NRIX Nurix Therapeutics, Inc.	$545M	$312,000 0.0% of portfolio	16,569	Q4 2024 Added 9.24%
AUPH Aurinia Pharmaceuticals Inc.	$1.16B	$307,000 0.0% of portfolio	34,251	Q4 2024 Added 19.62%
JANX Janux Therapeutics, Inc.	$1.29B	$301,000 0.0% of portfolio	5,637	Q4 2024 Added 56.19%
OCUL Ocular Therapeutix, Inc	$593M	$296,000 0.0% of portfolio	34,741	Q4 2024 Added 8.63%
RCKT Rocket Pharmaceuticals, Inc.	$547M	$294,000 0.0% of portfolio	23,447	Q4 2024 Added 24.94%
ABUS Arbutus Biopharma Corp	$493M	$293,000 0.0% of portfolio	89,665	Q4 2024 Added 139.09%
ARVN Arvinas, Inc.	$482M	$288,000 0.0% of portfolio	15,025	Q4 2024 Added 49.32%
HRMY Harmony Biosciences Holdings, Inc.	$1.75B	$281,000 0.0% of portfolio	8,177	Q4 2024 Added 58.81%
LQDA Liquidia Corp	$900M	$267,000 0.0% of portfolio	22,772	Q4 2024 Added 21.72%
LGND Ligand Pharmaceuticals Inc	$1.82B	$257,000 0.0% of portfolio	2,399	Q2 2024 Reduced 0.04%
SNDX Syndax Pharmaceuticals Inc	$754M	$237,000 0.0% of portfolio	17,991	Q4 2024 Added 47.23%
KURA Kura Oncology, Inc.	$430M	$231,000 0.0% of portfolio	26,630	Q4 2024 Added 47.45%
PRTA Prothena Corp Public LTD CO	$455M	$222,000 0.0% of portfolio	16,030	Q4 2024 Added 56.6%
VIR Vir Biotechnology, Inc.	$812M	$219,000 0.0% of portfolio	29,879	Q4 2024 Added 18.42%
AKRO Akero Therapeutics, Inc.	$1.9B	$218,000 0.0% of portfolio	7,845	Q2 2024 Reduced 0.01%
IMVT Immunovant, Inc.	$3.55B	$215,000 0.0% of portfolio	7,844	Q4 2024 Reduced 1.02%
EWTX Edgewise Therapeutics, Inc.	$937M	$210,000 0.0% of portfolio	7,891	Q4 2024 Reduced 3.31%
CDMO Avid Bioservices, Inc.	$776M	$195,000 0.0% of portfolio	15,790	Q4 2024 Added 14.91%
SVRA Savara Inc	$366M	$195,000 0.0% of portfolio	63,616	Q4 2024 Added 44.56%
DAWN Day One Biopharmaceuticals, Inc.	$569M	$180,000 0.0% of portfolio	14,269	Q4 2024 Added 104.49%
MRVI Maravai Lifesciences Holdings, Inc.	$270M	$164,000 0.0% of portfolio	30,117	Q4 2024 Added 18.34%
TBPH Theravance Biopharma, Inc.	$651M	$159,000 0.0% of portfolio	16,978	Q3 2024 Added 29.1%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.